ObjectiveTo investigate the clinical efficacy and safety of ultrasound-guided percutaneous microwave ablation in the treatment of hepatic hemangioma. MethodsA total of 80 patients with hepatic hemangioma were selected as research objects, and they were divided into control group and observation group by the random number table method, with 40 cases in each group. Patients in the control group were treated by open laparotomy, while patients in the observation group were treated by ultrasound-guided percutaneous microwave ablation. The treatment effect, liver function indicators and occurrence complications were compared between the two groups. ResultsThere was no statistically significant difference in the treatment effect between the two groups (P＞0.05). The levels of total bilirubin (TBil), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) between the two groups had no significant difference before operation (all P＞0.05). After operation, the levels of TBil, ALT and AST in both groups were lower than those before operation, which were lower in the observation group than in the control group (all P＜0.05). The incidence of complications in the observation group was 5.00%, which was lower than that in the control group (22.50%) (P＜0.05). ConclusionIn the treatment of hepatic hemangioma, ultrasound-guided percutaneous microwave ablation can achieve a comparable efficacy with open laparotomy and is more beneficial for improving patients′ liver function and reducing the incidence of complications, which is worthy of wide clinical application.

无